| 000 | 01783 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515211650.0 | ||
| 264 | 0 | _c20100721 | |
| 008 | 201007s 0 0 eng d | ||
| 022 | _a1573-2665 | ||
| 024 | 7 |
_a10.1007/s10545-010-9059-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTylki-Szymanska, Anna | |
| 245 | 0 | 0 |
_aEfficacy of recombinant human alpha-L-iduronidase (laronidase) on restricted range of motion of upper extremities in mucopolysaccharidosis type I patients. _h[electronic resource] |
| 260 |
_bJournal of inherited metabolic disease _cApr 2010 |
||
| 300 |
_a151-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aActivities of Daily Living |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aArthrometry, Articular |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aElbow Joint _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Replacement Therapy _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIduronidase _xtherapeutic use |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMovement _xdrug effects |
| 650 | 0 | 4 |
_aMucopolysaccharidosis I _xdrug therapy |
| 650 | 0 | 4 |
_aRange of Motion, Articular _xdrug effects |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aSelf Care |
| 650 | 0 | 4 |
_aShoulder Joint _xdrug effects |
| 650 | 0 | 4 |
_aWrist Joint _xdrug effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMarucha, Jolanta | |
| 700 | 1 | _aJurecka, Agnieszka | |
| 700 | 1 | _aSyczewska, Malgorzata | |
| 700 | 1 | _aCzartoryska, Barbara | |
| 773 | 0 |
_tJournal of inherited metabolic disease _gvol. 33 _gno. 2 _gp. 151-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10545-010-9059-9 _zAvailable from publisher's website |
| 999 |
_c19583917 _d19583917 |
||